A5020733921- Congenital Heart Disease Studies
- Cardiovascular and Diving-Related Complications
- Cardiac Valve Diseases and Treatments
- Cardiac Arrhythmias and Treatments
- Pulmonary Hypertension Research and Treatments
- Cardiovascular Conditions and Treatments
- Coronary Artery Anomalies
- Vascular anomalies and interventions
- Aortic Disease and Treatment Approaches
- Mechanical Circulatory Support Devices
- Cardiac pacing and defibrillation studies
- Cardiac Structural Anomalies and Repair
- Renal and Vascular Pathologies
- Cardiovascular Syncope and Autonomic Disorders
- Transplantation: Methods and Outcomes
- Tracheal and airway disorders
- Infective Endocarditis Diagnosis and Management
- Cardiovascular Issues in Pregnancy
- Central Venous Catheters and Hemodialysis
- Atrial Fibrillation Management and Outcomes
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Vascular Anomalies and Treatments
- Congenital Diaphragmatic Hernia Studies
- Neonatal Respiratory Health Research
- Neuroscience of respiration and sleep
Medical University of Silesia
2015-2024
Silesian Center for Heart Disease
2015-2024
University of Silesia in Katowice
2014
Górnośląskie Centrum Medyczne
2011-2013
Fondation pour la Recherche Stratégique
2008
Kardio-Med Silesia
2007
Medicina
2003
New York Academy of Medicine
2001
Szpital Kliniczny Dzieciątka Jezus
2001
Hospital Universitario Ramón y Cajal
1997
Left ventricular noncompaction (LVNC) is a genetically and phenotypically heterogeneous disease and, although increasingly recognized in clinical practice, there lack of widely accepted diagnostic criteria. We sought to identify novel genetic causes LVNC describe genotype-phenotype correlations.A total 190 patients from 174 families with left hypertrabeculation (LVHT) or were referred for cardiac magnetic resonance whole-exome sequencing. A 425 control individuals included variants interest...
<b>Background:</b> Transcatheter closure of a perimembranous ventricular septal defect (PmVSD) is usually performed with an asymmetric Amplatzer occluder, which not ideal device. Experience the use muscular occluder (MVSO) to close selected PmVSDs presented. <b>Setting:</b> Two tertiary referral centres for paediatric cardiology in two countries. <b>Objective:</b> To look at safety and efficacy application MVSO patients appropriate PmVSD anatomy. <b>Patients intervention:</b> The procedure...
Transcatheter closure of single secundum atrial defects has become the standard treatment. The purpose our study was to analyze results using a Amplatzer device for double septal defects. Such were diagnosed in 41 out 363 patients with (ASDs) closed by transcatheter method. In 39, used. size larger defect ranged from 5 18 mm, smaller 2 7 distance between borders communications ranging 12 mm. We performed sizing and only defect. mean implanted devices 16.5 +/- 5.5 equal stretched diameter...
Transcutaneous pulmonary valve replacement (TPVR) has become an alternative to heart surgery for patients after previous right ventricular outflow tract (RVOT) or artery (PA) surgical interventions. The objective was present immediate and long-term outcomes of trans¬cutaneous replacement.Between 06/2009 06/2016, 46 underwent TPVR. Initial diagnoses included tetralogy Fallot, common arterial trunk, transposition great arteries post Rastelli correction, left ventricle obstruction Ross...
Transcatheter closure of atrial septal defect (ASD) in older children and adults is currently considered the first-choice therapeutic option. This approach remains challenging younger children. The aim study was to evaluate feasibility, safety midterm efficacy percutaneous ASD symptomatic infants ≤10 kg body weight our institution.There were 28 up 10 weight, who qualified for transcatheter ASD. All patients but one showed overload right atrium ventricle. Mean underwent 9.2 ± 0.88 age 1.59...
Atrial septal defect (ASD) type 2, according to current standards, is closed percutaneously usually after the child has reached age of four five years. There are limited data regarding such treatment in younger infants.We sought evaluate feasibility, safety, and efficacy percutaneous ASD closure children under three years age.The research group consisted 157 less than old with haemodynamically significant ASD, who underwent effective transcatheter a single tertiary centre between 1999 2014....
The purpose of this study was to assess the effectiveness cardiac resynchronization therapy (CRT) in terms outflow tract gradient reduction and functional improvement symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM) requiring implantable cardioverter-defibrillator (ICD) implantation.Eleven consecutive HOCM a significant (≥40 mmHg) indications for ICD, but without resynchronization, underwent CRT-D implantation. Nine them (four female, median age 50 years) whom...
The aim of this study is to present our experience with a new type extra-large stent, namely the AndraStent XL/XXL.AndraStents were implanted in 46 patients, 38 native coarctation aorta (CoA) and eight recurrent following previous surgery (ReCoA). All patients had arterial hypertension upper limbs, absent or weak femoral pulses, continuous flow abdominal on Doppler examination. median age was 25 years (range from nine 65). stents (cobalt-chromium semi-open cell design) manually mounted...
Background: Transcatheter patent ductus arteriosus (PDA) closure has become the first‑choice method of treatment in majority patients. However, device selection poses a challenge. Aims: This study aimed to analyze periprocedural and 1‑year outcomes PDA transcatheter performed with different devices throughout 25‑year time period single center. Methods: All 1036 patients who underwent between 1993 2020 were included retrospective analysis. Various used: Rashkind (RD; n = 25), coils (n 469),...
A 19-year-old woman with atrial septal defect treated percutaneously an Amplatzer Septal Occluder 24 months earlier, who presented a history of bacterial meningitis, was admitted diagnosis endocarditis. After 6 weeks treatment antibiotics, the incompletely endothelialised occluder surgically removed. The present report illustrates need for long-term follow-up patients have received nitinol wire mesh occluders.
Transcatheter closure of atrial septal defect (ASD) has become the treatment choice for most patients. About 5% them suffer from transient headache episodes (THE) after procedure, whose etiology is unclear.To evaluate risk factors THE occurrence transcatheter ASD in pediatric population.Eight hundred and forty patients, with nitinol devices, a single center, were included retrospective analysis. was defined as occurring up to 24 hours procedure. A logistic regression model including age,...